Physiology of Bone Flashcards

1
Q

What are the main functions of bone?

A
  • support
  • movement
  • protection
  • mineral storage
  • blood cell formation
  • energy storage
  • energy metabolism
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the 4 different types of bone cells and their general function?

A
  • osteoclast: resorbs bone
  • osteogenic cell: stem cell
  • osteoblast: forms bone matrix
  • osteocyte: maintains bone tissue
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the organic components of bone ECM?

A

(~35% of tissue mass)

  • organic substances, particularly collagen, contribute to the flexibility and tensile strength that allow bone to resist stretching and twisting
  • osteonectin and osteocalcin: aid in hydroxyl apatite crystallization and bind calcium
  • proteoglycans: bind growth factors (TGF-beta)
  • sialoproteins, osteopontin, and thrombospondin: mediate osteoclast adhesion to bone surface (bind osteoclast integrins)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the inorganic components of bone ECM?

A

(~65% of tissue mass)

  • consists of inorganic hydroxyapatites or mineral salts, primarly calcium phosphate (some calcium carbonate, K, and Mg)
  • present as tiny crystals to lie in and around collagen fibrils in ECM
  • pack tightly, contributing to hardness and ability to resist compression
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q
  • type of bone cell
  • stem cells: differentiate into bone-forming osteoblasts
  • location: within inner layer of periosteum and the marrow
A

osteogenic cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q
  • type of bone cell
  • cuboidal shaped cells that are dervied from mesenchymal stem cells
  • location: growing portions of bone including, periosteum and endosteum
  • directly: regulate bone matrix synthesis and mineralization
  • indirectly: control bone resorption through release of paracrine factors that regulate osteoclasts (RANKL/OPG)
  • will become: osteocytes (embedded in matrix), bone lining cells (protect inactive bone surfaces), and initiate apoptosis
A

osteoblasts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q
  • type of bone cell
  • terminally differentiated osteoblasts
  • location: trapped within newly deposited bone matrix
  • smaller than osteoblasts and contain projections into matrix
  • respond to mechanical loading by releasing paracrine factors (stimulate and coordinate bone remodeling and calcium release)
  • maintain mineral concentration of matrix
A

osteocytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q
  • type of bone cell
  • specialized cells that resorb mineralized bone matrix
  • location: bone surfaces and site of old injured bone matrix
  • secrete acid and lytic enzymes
  • multinucleated, derived from mononuclear cells in bone marrow
  • differentiation controlled by receptor activator of nuclear factor κβ (RANKL) from osteoblasts (can be inhibited by OPG which sequesters RANKL)
A

osteoclasts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q
  • law that states: bone reacts to mechanical functional stress through an adaptive process resulting in a change of its external and internal architecture to better withstand stress
  • if loading on a particular bone increases, the bone will remodel itself over a period of time to withstand greatest strength with least amount of material
A

Wolff’s Law

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the importance of the bone remodeling cycle?

A

the cycle is important to repair microdamage, maintain strength, and maintain serum calcium in normal physiological range

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Describe the bone remodeling process:

A
  • microdamage or change in mechanical stress occurs
  • activation of osteoclast progenitors
  • osteoclastic bone resorption
  • reversal (apoptotic osteoclast along with growth factors activates mesenchymal stem cell to differentiate into osteoblasts)
  • osteoblastic bone formation occurs
  • mineralization and osteocytogenesis occurs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Describe the RANKL/OPG regulation on bone remodeling:

A
  • RANKL is produced by osteoblasts: high driver of proliferation and differentiation of osteoclasts from progenitors (activated by RANKL, have a RANK receptor that binds to RANKL)
  • OPG is a mock receptor for RANKL and sequesters it, preventing it from activating additional osteoclasts, thus preventing further bone resorption
  • there is a ratio of RANKL to OPG to prevent overabundance of bone resorption
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q
  • stimulate the proliferation and differentiation of osteoblasts and bone formation
  • increase OPG production
A

transforming growth factors-β (TGF-β)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q
  • potent inducers of osteoblasts and bone formation
  • regulate matrix production
  • used clinically: rhBMP-2 in fracture healing and spinal fusion
A

bone morphogenic proteins (BMPs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q
  • secreted from osteoblasts
  • binds RANKL sequestering it and preventing osteoclast activation
A

osteoprotegerin (OPG)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q
  • increase proliferation of osteoblasts
  • enhance callus formation during fracture repair
  • FGF-2 stimulates angiogenesis during fracture repair
A

fibroblast growth factors (FGFs)

17
Q
  • stimulated by growth hormone
  • increases bone collagen matrix synthesis and inhibits degradation
A

insulin-like growth factors (IGFs)

18
Q
  • increases collagen synthesis
A

platelet derived growth factor (PDGF)

19
Q
  • secreted from osteoblasts
  • activates osteoclasts for bone resorption
  • regulated by OPG
A

RANKL

20
Q
  • stimulate bone resorption
  • IL-1 is the most potent
  • IL-1 expression is decreased by estrogen (possible mechanism for post-menopausal bone resorption increases)
A

interleukins

21
Q
  • falling blood Ca (hypocalcemia) signal parathyroid gland to release this hormone
  • this hormone signals osteoclasts to degrade bone matrix and release Ca into blood
A

parathyroid hormone (PTH)

22
Q
  • specialized type of wound healing
  • sequence of inflammation, repair, and remodeling
  • healing sequence depends on amount of movement between fragments: limited movement (indirect healing) and no movement (direct healing)
A

fracture healing

23
Q

Describe the process of indirect (secondary) fracture healing:

A

5 stages

  1. tissue destruction and hematoma: tissue damage leads to increased blood flow and cytokines, causing a hematoma
  2. inflammatory phase (~1 week): driven by cytokines TGF-beta and PDGF, stimulates new blood vessel formation and recruit mesenchymal stem cells which proliferate and become osteoprogenitor cells, osteoclasts also recruited to clear out dead bone tissue
  3. soft callus formation (weeks 2-3): made up of fibrous connective tissue, limits movement of bone fragments
  4. hard callus formation (weeks 4-12): occurs when soft callus is replaced by bone matrix in the form of woven bone; produced by osteoclasts and osteoblasts by removing connective tissue and replacing it w/ bone matrix (RANKL and OPG play important roles in this phase)
  5. remodeling of bone (years): hard callus is replaced by additional bone remodeling (malar bone and angiogenesis)
24
Q

Describe the process of direct (primary) fracture healing:

A
  • contact healing between bones
  • no callus is formed
  • requires absolute stability between fracture fragments (no motion): rigid internal fixation
  • components of direct fracture healing: contact healing (direct contact between fragment ends > lamellar bone), gaps 200-500 nm (woven bone > lamellar), gaps 500 nm (indirect healing)
25
Q

What are some anti-resorption treatments for bone loss?

A
  • bisphosphonates: inhibit osteoclast activity, induce osteoclast apoptosis
  • hormone replacement (estrogen)
  • selective estrogen receptor modulators
  • Denosumab (Prolia): a monoclonal antibody against RANK ligand
26
Q

What are some anabolic agents for treatment of bone loss?

A
  • BMP-2: induces osteoblast proliferation and activity for increased bone matrix production
  • parathyroid horomone (PTH): continual administration of PTH is catabolic for bone, w/ increased osteoclast formation due to changes in expression of OPG and RANKL by osteoblasts; however, intermittent (daily) administration is anabolic, w/ reductions in vertebral fractures of up to 70% being reported over untreated patients, the exact mechanism by which these competing effects is regulated is still not completely understood
27
Q

How does estrogen regulate bone formation?

A
  • stimulates fracture healing through receptor mediated mechanisms
  • decreases RANKL production from osteoblasts
  • modulates release of a specific inhibitor of Interleukin-1 (IL-1 strongly causes bone resorption)
28
Q

How do thyroid hormones regulate bone formation?

A
  • thyroxine and triiodothyronine stimulate osteoclastic bone resorption
29
Q

How do glucocorticoids regulate bone formation?

A
  • inhibit calcium absorption from gut causing increased PTH and therefore, increased osteoclastic bone resorption
30
Q

How does parathyroid hormone (PTH) regulate bone formation?

A
  • intermittent exposure stimulates: osteoblasts, increased bone formation
  • chronic exposure or pathological levels (hyperparathyroidism): stimulates osteoclasts to release calcium, can lead to hypercalcemia
31
Q

How does growth hormone regulate bone formation?

A
  • mediated through IGF-1
  • increases callus formation and fracture strength by stimulating osteoblasts